Member Info for crowfoot

Myhero #eyesraisedemoji

'at a suitable point'
That'll be right about now then! :o)

I agree wholeheartedly :o)

Cebo, with all due respect flipping placing shares is common practice on small cap AIM companies. PI's don't get a look in of course although you could have bought in first thing around 133. Hopefully most go into sticky hands if they have done any research.

I agree GT, unfortunately I'm sure many of them will be flipped for a quick 10-20% return. Still won't hold it back for too long as the fundamentals are clearly strong. PDSB could also rocket at any time, ProAxsis value far too low, Glycotest news due soon...

They need money because they are an investment company and it's very difficult to negotiate with nothing in the coffers. I'm delighted they are raising now instead of at 60p a fortnight ago which was a worry. The current price will double in no time once this has churned through. GLA

ImpotentFart and his fellow shorts will be all hot and bothered no doubt. GLA

PDSB up 23% @ $11.60 pre-market

PDSB is currently up pre-market 11% @ $10.46

Nothing would surprise me but I do think we will be seeing 200p breached over the next few sessions, maybe even hours knowing how this can move! I think the attack on PDSB yesterday has also caused a little extra volatility but all good fun. I've bought back the ones I sold on the spike first thing and now holding strong until the next craziness. GLA

Seems to have been caused by some twitter folk:
PDS Biotechnology Shares Halted On Circuit Breaker; Traders Circulate Avid Research Tweet 'PD1 R/R historical median survival is very low 3-4 months (end stage survival). ORR in PD1R/R goes from 63% to 41.7% but now that its from N=12,...'

FLORHAM PARK, N.J., June 07, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology
Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing
novel cancer therapies based on the Company’s proprietary Versamune(®)
T-cell activating technology, today announced the Company is set to join the
Russell Microcap(®) Index at the conclusion of the 2021 Russell indexes
annual reconstitution, effective after the US market opens on June 28,
according to a preliminary list of additions posted June 4.

Membership in the Russell Microcap(®) Index, which remains in place for one
year, means automatic inclusion in the appropriate growth and value style
indexes. FTSE Russell determines membership for its Russell indexes primarily
by objective, market-capitalization rankings and style attributes.

"Inclusion in the Russell Microcap Index underscores the progress we are
making to increase shareholder value by driving our three (3) Phase 2 clinical
programs forward for our lead HPV-cancer immunotherapy PDS0101, including an
oral presentation of interim data for our National Cancer Institute-led trial
at the American Society of Clinical Oncology annual meeting later today," said
Dr. Frank Bedu-Addo, President and CEO of PDS Biotech. "Inclusion in the Index
significantly benefits our Company and shareholders by elevating our
visibility within the global investment community. We look forward to
continuing to progress the clinical development of PDS0101 while also moving
additional oncology pipeline products into human testing within the next
year."

I'm just saying it's new on the site today in my opinion, it might not be our test. RNS also have to be written, checked and submitted so not something that happens automatically in real time. If it is our test we still might not get the RNS on Monday 7am...

Not sure how they could have registered a device for SARS-CoV-2 on 26/11/2019 when it wasn't even reported until December 2019! :o)

LLnP, it also states the same info if you search for their other device 'Multiple peritonitis marker IVD kit immunochromatographic test (ICT) rapid' but I'm pretty sure it's been added recently.

Not sure if this has been spotted yet but I think the 'SARS-CoV-2 antigen IVD kit immunochromatographic test (ICT) rapid' has been added today.
https://aic.mhra.gov.uk/era/pdr.nsf/vwLkupFileRef/9288?opendocument

I added some after the 9am auction was out of the way, no bargains in there. Sentiment obviously very low here after all the negative press and still priced to fail in my opinion. Going to be a sharp rerate if successful with PacifiCorp...

Looking much better today. Decent volume and very little selling so far. First real resistance looks to be at 90p. GLA

MagnifEye Production Contract with UK DHSC

Tue, 1st Jun 2021 07:00

RNS Number : 3067A
Sensyne Health PLC
01 June 2021

MagnifEye Production Contract with the UK's Department of Health & Social Care

Oxford, U.K. 01 June 2021: Sensyne Health plc (LSE: SENS) ("Sensyne" or the "Company" or the "Group"), the Clinical AI technology company, today announces it has signed a production contract with the UK's Department of Health & Social Care (DHSC) to use Sensyne's MagnifEye AI technology for reading COVID-19 lateral flow diagnostic tests as part of the UK government's asymptomatic testing programme.



The scope of this contract with DHSC is for a phased national roll-out over a three-month period in care homes, GP practices and selected private sector organisations with large workforces. Revenues will be shared with Excalibur Health Systems under the terms of the exclusive agreement between the two companies.



Lord (Paul) Drayson PhD, CEO of Sensyne Health, said:

"This is a significant commercial milestone in Sensyne's development and underlines the potential of our world-class expertise in clinical AI applied to diagnostic testing. We are delighted to be working with the Department of Health & Social Care to support the UK's national COVID testing programme, which is making a huge impact in helping the nation to recover from the pandemic."

I’m not disagreeing that Rowan has done a poor job of getting the plant up to production. I’m questioning if replacing him right at this moment would be of benefit to the owners of the company. I would like to see where we are in a couple of months.